Hepatocyte growth factor/cMet axis- mediated crosstalk between gliomas and stem cells

M. Rapp, M. Sabel, G. Kögler, J. Fischer, H.-J. Steiger & T. Trapp
Objective: In spite of improved knowledge and advanced treatments of gliomas, the overall survival rate for glioma patients remains low. Gliomas comprise significant cell heterogeneity and contain a large number of multidrug resistant phenotypes and cancer stem cells. An understanding of the molecular[for full text, please go to the a.m. URL]